Business Daily | by Brian Ngugi
American biotechnology firm Moderna now says its plans to start filling doses of its Covid-19 vaccine locally to serve Africa from next year will be based on demand.
The firm announced the development in regulatory filings last week. It revealed in the update its other key plan to build a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) vaccines, including Covid-19 shots is firmly on course…
